3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Hematologic Diseases
1
Interventions
trametinib
4
dabrafenib
4
encorafenib
3
Oxaliplatin
3
zolbetuximab
2
selpercatinib
2
pembrolizumab
2
lenvatinib
2
larotrectinib
2
dostarlimab
2
binimetinib
2
Leucovorin
2
Fulvestrant
2
Fluorouracil
2
Cetuximab
2
Capecitabine
2
trastuzumab deruxtecan
1
tepotinib
1
telisotuzumab vedotin
1
ribociclib
1
repotrectinib
1
relatlimab
1
pralsetinib
1
pegaspargase
1
niraparib
1
blinatumomab
1
avelumab
1
asparaginase erwinia chrysanthemi recombinant
1
adagrasib
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Neoplasms
×
Brentuximab Vedotin
×
Clear all
No trials found.